This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 01/12/2020
Location: San Francisco, CA
Subject: UCSF - Stanford Center of Excellence in Regulatory Science (CERSI) - Innovations in Regulatory Science Summit; Panel: Accelerating Clinical Trials in the Development and Approval of Innovative Med Prd
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Government, industry, academia, and other stakeholders

Event Date: 01/12/2020
Location: San Francisco, CA
Subject: Friends of Cancer Research: Individualization of Drug Development Roundtable
FDA Participant/Group: JANET WOODCOCK; JANET MAYNARD; PETER MARKS; MAARIKA KIMBRELL; JULIA TIERNEY;
Non FDA Participant/Group: Patients, industry, academia, and the health care services field

Event Date: 01/13/2020
Location: San Francisco, CA
Subject: Mayfield Healthcare Innovators Summit; Speaker: Role of FDA in Enabling Healthcare Innovation
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, and other stakeholders

Event Date: 01/15/2020
Location: Washington, DC
Subject: Cannabidiol (CBD) Summit: A National Dialogue on Public Safety, Research, and Policy
FDA Participant/Group: N/A
Non FDA Participant/Group: Patients, industry, government, and other stakeholders

Event Date: 01/16/2020
Location: Silver Spring, MD
Subject: Listening Session with Charlotte’s Web
FDA Participant/Group: RANDALL GNATT; STEVEN TAVE; ALISON THOMPSON; KRISTI HAMPTON; MELISSA ROBB; JASON HUMBERT; CARA WELCH; THOMAS BERRY; TRISTAN COLONIUS; JOSEPH FRANKLIN; SHARON MAYL; MICHAEL LEVY; LOWELL SCHILLER; SCOTT MACINTIRE; REBECCA GOLDBERG; APRIL ALEXANDROW; RACHEL OSTERMAN;
Non FDA Participant/Group: Deanie Elsner , Joel Stanley , Kelly Shea, Nathan Gerhardt, Tim Orr (Charlotte's Web); Arshi Siddiqui, Howard Sklamberg (Akin Gump);

Event Date: 01/16/2020
Location: Silver Spring, MD
Subject: Listening Session with the Cannabidiol (CBD) Coalition
FDA Participant/Group: ALISON THOMPSON; JOSEPH FRANKLIN; RACHEL OSTERMAN; CARA WELCH; LOWELL SCHILLER; SHARON MAYL; MICHAEL LEVY; MELISSA ROBB; CASSANDRA TAYLOR; DENNIS KEEFE; APRIL ALEXANDROW; STEVEN TAVE; REBECCA GOLDBERG; SHERENE SEPEHRI;
Non FDA Participant/Group: Brendan Carroll, Marc Scheineson (Alston & Bird LLP); Cynthia Bryant (Demetrix, Inc.); Bill Grubb (Noramco); Angelo Fefekos, Etan Bendheim, Jeremy Friedberg (LAVVAN, Inc.); Wendi Young (Mile High Labs); Josh Hoerner, Scott Warner (Purisys); Douglas “Duffy” McKay, Joseph Dowling (CV Sciences, Inc.); Trevor Peters (Willow Biosciences);

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 01/14/2020
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; SHARON MAYL; DONALD PRATER;
Non FDA Participant/Group: Jacqueline Southee (Foundation Food Safety System Certification 22000 (FSSC 22000));

Event Date: 01/14/2020
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Michael Dykes (International Dairy Foods Association);

Event Date: 01/15/2020
Location: Silver Spring, MD
Subject: Produce Safety Issues
FDA Participant/Group: LARRY MORRIS; DAVID GOLDMAN; CAITLIN BOON;
Non FDA Participant/Group: Dana Mullen Graber, Hilary Thesmar, Stephanie Harris (Food Marketing Institute);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

Event Date: 01/13/2020
Location: Silver Spring, MD
Subject: Listening Session with Mile High Labs
FDA Participant/Group: STEVEN TAVE; REBECCA GOLDBERG; MELISSA ROBB; CASSANDRA TAYLOR; RACHEL OSTERMAN; SHARON MAYL; APRIL ALEXANDROW; CARA WELCH; DOUGLAS THROCKMORTON; SHERENE SEPEHRI;
Non FDA Participant/Group: Keith Aqua, Laura Eder, Stephen Mueller, Wendi Young (Mile High Labs);

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Acting Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 01/17/2020
Location: Bethesda, MD
Subject: Inaugural NIH Helping to End Addiction Long-term (HEAL) Investigator’s Meeting; Panel: Collaborating for Success: Federal Partners in HEAL
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, scientific, academia, media, and other stakeholders

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/13/2020
Location: San Francisco, CA
Subject: Navigating Regenerative Medicine
FDA Participant/Group: N/A
Non FDA Participant/Group: Representatives from the California Institute for Regenerative Medicine and the Cura Foundation

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event